1686 related articles for article (PubMed ID: 29406966)
1. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
3. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
[TBL] [Abstract][Full Text] [Related]
4. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
5. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
6. Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
Zhang X; Li L; Qi L; Fu Y; Sun D; Chen S; Xu W; Liu C; Zhou X; He G
Neurosci Lett; 2023 Jun; 807():137249. PubMed ID: 37061026
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
[TBL] [Abstract][Full Text] [Related]
8. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
9. Free water and iron content in the substantia nigra at different stages of Parkinson's disease.
Chen M; Wang Y; Zhang C; Li J; Li Z; Guan X; Bao J; Zhang Y; Cheng J; Wei H
Eur J Radiol; 2023 Oct; 167():111030. PubMed ID: 37579561
[TBL] [Abstract][Full Text] [Related]
10. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
[TBL] [Abstract][Full Text] [Related]
11. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
[TBL] [Abstract][Full Text] [Related]
12. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
13. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
[TBL] [Abstract][Full Text] [Related]
15. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
16. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
17. 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2
Li G; Zhai G; Zhao X; An H; Spincemaille P; Gillen KM; Ku Y; Wang Y; Huang D; Li J
Neuroimage; 2019 Mar; 188():465-472. PubMed ID: 30578927
[TBL] [Abstract][Full Text] [Related]
18. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
19. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.
Jin L; Wang J; Jin H; Fei G; Zhang Y; Chen W; Zhao L; Zhao N; Sun X; Zeng M; Zhong C
Eur J Neurol; 2012 Jul; 19(7):969-76. PubMed ID: 22288465
[TBL] [Abstract][Full Text] [Related]
20. Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping.
Azuma M; Hirai T; Yamada K; Yamashita S; Ando Y; Tateishi M; Iryo Y; Yoneda T; Kitajima M; Wang Y; Yamashita Y
AJNR Am J Neuroradiol; 2016 May; 37(5):782-8. PubMed ID: 26822728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]